Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring hormones are secreted by the gut in response to meal intake, https://freebookmarkpost.com/story20328832/unveiling-the-therapeutic-potential-of-glp-1-peptides